Bloomberg Anywhere Remote Login Bloomberg Terminal Demo Request


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Roche Wins U.K. Backing for Expanded Use of Lymphoma Treatment

Roche Holding AG’s MabThera medicine won the backing of the U.K.’s National Institute for Health and Clinical Excellence in new draft guidance on the treatment of people with advanced follicular lymphoma.

Research shows that adding the drug to a greater number of chemotherapy regimens, including chlorambucil, helps patients live longer and improves quality of life, the institute, known as NICE, said in an e-mailed statement today. NICE advises the state-run National Health Service on which therapies represent value for money. The agency will publish final guidance on MabThera next month.

Please upgrade your Browser

Your browser is out-of-date. Please download one of these excellent browsers:

Chrome, Firefox, Safari, Opera or Internet Explorer.